Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population

Serum Levels of Adipocyte Fatty Acid–Binding Protein Are Independently Associated With Left Ventricular Mass and Myocardial Performance Index in Obstructive Sleep Apnea Syndrome

(2016) Mustafa Mücahit Balci et al.   JOURNAL OF INVESTIGATIVE MEDICINE

Adipocyte fatty acid-binding protein levels are associated with left ventricular diastolic dysfunction in morbidly obese subjects

(2014) A Baessler et al.   Nutrition & Diabetes

Capillary Endothelial Fatty Acid Binding Proteins 4 and 5 Play a Critical Role in Fatty Acid Uptake in Heart and Skeletal Muscle

(2013) Tatsuya Iso et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients

(2013) Anna Cabré et al.   Cardiovascular Diabetology

Influencing factors on cardiac structure and function beyond glycemic control in patients with type 2 diabetes mellitus

(2013) Ryoko Ichikawa et al.   Cardiovascular Diabetology

Association between serum adipocyte fatty-acid binding protein concentrations, left ventricular function and myocardial perfusion abnormalities in patients with coronary artery disease

(2013) Chi-Lun Huang et al.   Cardiovascular Diabetology

Adipocyte Lipid Chaperone aP2 Is a Secreted Adipokine Regulating Hepatic Glucose Production

(2013) Haiming Cao et al.   Cell Metabolism

Epidemiology of Heart Failure

(2013) Véronique L. Roger   CIRCULATION RESEARCH

Fatty acid binding protein 4 predicts left ventricular mass and longitudinal function in overweight and obese women

(2013) Stefan Engeli et al.   HEART

Circulating Levels of Fatty Acid-Binding Protein Family and Metabolic Phenotype in the General Population

(2013) Shutaro Ishimura et al.   PLoS One

Elevation of Fatty Acid-Binding Protein 4 Is Predisposed by Family History of Hypertension and Contributes to Blood Pressure Elevation

(2012) Hideki Ota et al.   AMERICAN JOURNAL OF HYPERTENSION

Circulating Adipocyte Fatty Acid-Binding Protein Levels and Cardiovascular Morbidity and Mortality in Patients With Coronary Heart Disease

(2012) Maximilian von Eynatten et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells

(2012) Gemma Aragonès et al.   Cardiovascular Diabetology

Predictors of New-Onset Heart Failure

(2012) Jennifer E. Ho et al.   Circulation-Heart Failure

Circulating adipocyte fatty acid-binding protein levels are independently associated with heart failure

(2012) Mingya Liu et al.   CLINICAL SCIENCE

Fatty acid-binding protein 4 and incident heart failure: the Cardiovascular Health Study

(2012) Luc Djoussé et al.   EUROPEAN JOURNAL OF HEART FAILURE

Serum Fatty Acid-Binding Protein 4 Is a Predictor of Cardiovascular Events in End-Stage Renal Disease

(2011) Masato Furuhashi et al.   PLoS One

Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients

(2010) Toru Miyoshi et al.   HEART AND VESSELS

The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease

(2010) D. Margriet Ouwens et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Adipocyte Fatty Acid–Binding Protein Suppresses Cardiomyocyte Contraction

(2009) Valéria Lamounier-Zepter et al.   CIRCULATION RESEARCH

Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome

(2008) Burcak Vural et al.   CARDIOVASCULAR PATHOLOGY

Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets

(2008) Masato Furuhashi et al.   NATURE REVIEWS DRUG DISCOVERY

Cardiac cachexia: A systematic overview

(2008) Stephan von Haehling et al.   PHARMACOLOGY & THERAPEUTICS